Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JTECTSE:3446 -2.19%64 Pretax Margin % is 34.62% as of Jun. 2026, which is 144% above its 10-year median of 14.16. GuruFocus rates TSE:3446 with a GF Score™ of 64/100 and a GF Value™ of 円1,801.44 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, JTEC ranks better than 52.14% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. JTEC's Pre-Tax Income for the
three
months ended in Jun. 2026 was 円317 Mil. JTEC's Revenue for the
three
months ended in Jun. 2026 was 円915 Mil. Therefore, JTEC's pretax margin for the quarter that ended in Jun. 2026 was 34.62%.
The historical rank and industry rank for JTEC's Pretax Margin % or its related term are showing as below:
TSE:3446'
s Pretax Margin % Range Over the Past 10 Years
Min: -2.43 Med: 14.16 Max: 38.55
Current: 4.39
TSE:3446's Pretax Margin % is ranked better than 52.14% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.99
vs TSE:3446: 4.39
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
JTEC Pretax Margin % Related Terms
JTEC Pretax Margin % Historical Data
* Premium members only.
The historical data trend for JTEC's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3446 vs ISRG, BDX, RMD: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, JTEC's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JTEC Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JTEC's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where JTEC's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JTEC (TSE:3446) has a Pretax Margin % of 34.62% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on JTEC and its competitors. This is 144% above median its historical median of 14.16. According to the industry distribution chart, JTEC ranks #391 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 47.9%.
Is JTEC's Pretax Margin % too high?
JTEC's current Pretax Margin % of 34.62% is 144% above median its 10-year median of 14.16. The Medical Devices & Instruments industry median Pretax Margin % is 2.99. JTEC's value of 34.62% is 1057.9% above this industry median. Based on the distribution chart, JTEC ranks #391 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JTEC has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #391 out of 817 companies for Pretax Margin %. This puts JTEC in the upper half of its industry. The industry median Pretax Margin % is 2.99. JTEC's value of 34.62% is 1057.9% above this benchmark. While the company's 10-year median is 14.16 vs. the industry median of 2.99, JTEC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.99, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JTEC's current Pretax Margin % of 34.62% is 1057.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on JTEC and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JTEC's current Pretax Margin % is 34.62%, which is 144% above median its own 10-year median of 14.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,801.44, compared to a current price of 円1,607.00 — trading 10.8% below its estimated fair value. The current Pretax Margin % is 34.62%, which is 144% above median its 10-year median of 14.16 and 1057.9% above the Medical Devices & Instruments industry median of 2.99. JTEC's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For JTEC (TSE:3446), the current Pretax Margin % is 34.62% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JTEC (TSE:3446) Overvalued in 2026?
Based on GuruFocus' analysis, JTEC stock appears to be undervalued.
The current stock price of 円1,607.00 is trading 10.8% below its estimated GF Value™ of 円1,801.44.
GuruFocus considers JTEC to be Modestly Undervalued.
Key valuation signals for TSE:3446:
Pretax Margin %: 34.62% (144% above median its 10-year median of 14.16)
GF Value™: 円1,801.44 vs. price of 円1,607.00 (10.8% below fair value)
Industry Position: 1057.9% above the Medical Devices & Instruments median (#391 of 817)
No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
64GF Score
Get the complete analysis for TSE:3446
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3446 has been successfully added to your 
